International Consortium Provides $2M Funding for Phase 1 Clinical Trial of ReveraGen DMD Drug

Disease: 
Link: 
Time Stamp: 
0
Thumbnail: 
https://mda_assets.s3.amazonaws.com/PR/2014/MDA_logo_FMD.png
Node Type: 
Quest News